Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024
Dr. Inamdar will speak at the following two panels:
- Dr. Inamdar will speak at the following two panels:
“Towards Marketing Approval of Psychedelics – Designing Trials and Engaging with Regulators” at the Pathways to Access Summit (PATHS), a pre-ICPR event, on Wednesday, June 5 at 10:20 a.m. Central European Time. - “Pathways to access in Europe” at ICPR on Saturday, June 8 at 2:20 p.m. Central European Time.
- Dr. James will present “ SPL026 (DMT fumarate) in combination with SSRIs for patients with Major Depressive Disorder ” on Thursday, June 6 at 2:40 p.m. Central European Time.
- Cybin is pleased to be a leader in bringing improved treatments to address the urgent needs in mental healthcare,” concluded Dr. Inamdar.